drugset / Trial / NCT00001431

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

NCT00001431 ↗

Phase 1 Completed 20 enrolled National Cancer Institute (NCI)
Treatment

Summary

Radiotherapy plus Single-Agent Chemotherapy/Radiosensitization. Involved-field irradiation using 4-15 MV photons; plus Gemcitabine, NSC-613327.

Timeline

Start
1995-02
Primary completion
—
Completion
2000-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —

Indications